Key result
Myopathy-causing Tpm3.12 p.R91C variant inhibits cofilin-2-dependent actin severing more than wild-type, impairing filament turnover.
Why the study?
Irregular thin filaments are common in myopathies linked to tropomyosin mutations, which may stem from defects in actin filament length maintenance mechanisms.
The myopathy-linked p.R91C variant in Tpm3.12 impairs cofilin-2-dependent actin filament turnover, which may contribute to the irregular thin filaments observed in skeletal muscle myopathies.
Uniform actin filament length is required for synchronized contraction of skeletal muscle. In myopathies linked to mutations in tropomyosin (Tpm) genes, irregular thin filaments are a common feature, which may result from defects in length maintenance mechanisms. The current work investigated the effects of the myopathy-causing p.R91C variant in Tpm3.12, a tropomyosin isoform expressed in slow-twitch muscle fibers, on the regulation of actin severing and depolymerization by cofilin-2. The affinity of cofilin-2 for F-actin was not significantly changed by either Tpm3.12 or Tpm3.12-R91C, though it increased two-fold in the presence of troponin (without Ca2+). Saturation of the filament with cofilin-2 removed both Tpm variants from the filament, although Tpm3.12-R91C was more resistant. In the presence of troponin (±Ca2+), Tpm remained on the filament, even at high cofilin-2 concentrations. Both Tpm3.12 variants inhibited filament severing and depolymerization by cofilin-2. However, the inhibition was more efficient in the presence of Tpm3.12-R91C, indicating that the pathogenic variant impaired cofilin-2-dependent actin filament turnover. Troponin (±Ca2+) further inhibited but did not completely stop cofilin-2-dependent actin severing and depolymerization.
No takes yet. Share an insight, caveat, or question.
Robaszkiewicz et al. (2023) studied Myopathy. Tpm3.12-R91C variant vs. Wild-type Tpm3.12 was evaluated on Actin filament severing and depolymerization by cofilin-2. The myopathy-causing p.R91C variant in Tpm3.12 inhibited cofilin-2-dependent actin filament severing and depolymerization more efficiently than wild-type Tpm3.12, impairing actin filament turnover.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: